A detailed history of National Bank Of Canada transactions in Abb Vie Inc. stock. As of the latest transaction made, National Bank Of Canada holds 1,244,546 shares of ABBV stock, worth $224 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
1,244,546
Previous 1,244,546 -0.0%
Holding current value
$224 Million
Previous $246 Million -0.0%
% of portfolio
0.34%
Previous 0.34%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $12 Million - $14.6 Million
73,383 Added 6.27%
1,244,546 $246 Million
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $50.7 Million - $59.2 Million
327,478 Added 38.82%
1,171,163 $201 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $143 Million - $163 Million
-896,538 Reduced 51.52%
843,685 $154 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $4.8 Million - $5.4 Million
-34,868 Reduced 1.96%
1,740,223 $270 Million
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $44 Million - $51 Million
329,615 Added 22.8%
1,775,091 $265 Million
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $90.1 Million - $112 Million
679,804 Added 88.79%
1,445,476 $195 Million
Q1 2023

Apr 12, 2023

BUY
$144.61 - $166.54 $33 Million - $38 Million
228,000 Added 42.41%
765,672 $122 Million
Q4 2022

Jan 24, 2023

BUY
$138.31 - $165.87 $18.4 Million - $22.1 Million
133,314 Added 32.97%
537,672 $0
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $6.4 Million - $7.34 Million
47,673 Added 13.37%
404,358 $55.7 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $986,735 - $1.25 Million
-7,170 Reduced 1.97%
356,685 $56.1 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $2.2 Million - $2.73 Million
16,646 Added 4.79%
363,855 $60.2 Million
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $37.3 Million - $47.2 Million
347,209 New
347,209 $48.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.